Covid 19 Autoantibodies - Infectious Diseases

Relevant Publications

Cellular pathways and molecular events that shape autoantibody production in COVID-19.

Issue Release: 2024

ANCA-Positive Small-Vessel Vasculitis Following SARS-CoV-2 Vaccination-A Systematic Review.

Issue Release: 2024

The Onset of Antinuclear Antibodies (ANAs) as a Potential Risk Factor for Mortality and Morbidity in COVID-19 Patients: A Single-Center Retrospective Study.

Issue Release: 2024

Earlier vs. later time period of COVID-19 infection and emergent autoimmune signs, symptoms, and serologies.

Issue Release: 2024

G protein-coupled receptors related to autoimmunity in postural orthostatic tachycardia syndrome.

Issue Release: 2024

Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients.

Issue Release: 2024

Thrombosis With Thrombocytopenia and Post-COVID-Vaccination Syndrome With Anti-G-Protein-Coupled Receptor (GPCR) Antibodies Treated With Therapeutic Plasma Exchange.

Issue Release: 2024

Autoimmune hepatitis after COVID-19 infection.

Issue Release: 2024

[Management of HIT/anti-PF4 disorders].

Issue Release: 2024

Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients.

Issue Release: 2024

Autoantibodies in COVID-19 and Other Viral Diseases: Molecular, Cellular, and Clinical Perspectives.

Issue Release: 2024

A Comprehensive Review on the Intricate Interplay between COVID-19 Immunization and the New Onset of Pemphigus Foliaceus.

Issue Release: 2024

Onset of Type I Diabetes Followed by Scleroderma Syndrome in a Child After the COVID-19: A Case Report.

Issue Release: 2024

No link between type I interferon autoantibody positivity and adverse reactions to COVID-19 vaccines.

Issue Release: 2024

Movement disorders associated with pediatric encephalitis.

Issue Release: 2024

Enhancement of NETosis by ACE2-cross-reactive anti-SARS-CoV-2 RBD antibodies in patients with COVID-19.

Issue Release: 2024

Autoantibodies in post-treatment Lyme disease and association with clinical symptoms.

Issue Release: 2024

Human autoantibodies neutralizing type I IFNs: From 1981 to 2023.

Issue Release: 2024

Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches.

Issue Release: 2024

Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.

Issue Release: 2024

What are the Symptoms of Measles?

What Challenges Exist in Targeting Structural Proteins?

How Does the CDC Educate the Public About Infectious Diseases?

What are the Phases of the Inflammatory Response?

How Do Infectious Diseases Affect Lipid Metabolism?

What is the Role of Public Health in Managing Infectious Diseases?

How Can Education Help in the Prevention of Infectious Diseases?

What are the Benefits of Gene Therapy and Immunotherapy?

Are Asymptomatic Infections Less Severe?

What are the Symptoms of ARDS?

Partnered Content Networks

Relevant Topics